MedPath
NMPA Approval

Cefdinir Granules

国药准字H20233397

April 4, 2023

Drug Information

头孢地尼颗粒

颗粒剂

50mg

化学药品

April 4, 2023

Company Information

Applicant Company

安徽省合肥市肥西县经济开发区文山路10号

Manufacturing Company

铜陵市经济开发区新城区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

头孢地尼颗粒 - NMPA 批准文号 | MedPath